Who is suitable for using Fezonatant? Who can use this medicine?
Fezolinetant (fezolinetant) is a new medicine mainly used to relieve common symptoms in perimenopausal and menopausal women, such as hot flashes (hot flashes). It improves uncomfortable symptoms caused by hormone fluctuations by regulating the balance of hormones in the body. Fezonatant is not a hormonal drug, but relieves symptoms by regulating specific receptors in the brain. It is suitable for use by the following specific groups of people:
1. Perimenopausal and menopausal women: Fezonastat is mainly suitable for perimenopausal and menopausal women. These women often experience fluctuations in hormone levels, resulting in uncomfortable symptoms such as hot flashes and night sweats. Hot flashes are the most common symptom among menopausal women. Fezonastat relieves these symptoms and improves patients' quality of life by regulating the body's temperature regulation system.
2. Women who are intolerant to hormone replacement therapy (HRT): Many women choose hormone replacement therapy (HRT) during perimenopause or menopause to relieve symptoms such as hot flashes. However, some women have adverse reactions to hormone therapy, such as breast tenderness, nausea, headaches, etc., or are unable to use hormone therapy due to other health problems. Fezonatant, a non-hormonal drug, offers these women an alternative that relieves symptoms through a different mechanism without relying on hormonal components.
3. High-risk patients: Some patients cannot be treated with hormone drugs because they suffer from hormone-dependent diseases (such as breast cancer, endometrial cancer, etc.) or cardiovascular disease. Fezonatant does not contain hormones, making it a safer treatment option for these high-risk patients without increasing the risk of hormone-related diseases.
4. Patients with inadequate symptom control: For women who have tried other treatments (eg, antidepressants, anti-anxiety drugs) but failed to respond, Fezonatan provides a new treatment option. In these women, symptoms such as hot flashes are not adequately controlled by traditional treatments, and fezonatant can help relieve these symptoms through a different mechanism of action.
In general, fezonatant is suitable for perimenopausal and menopausal women, especially those who are intolerant to hormone therapy, cannot use hormone therapy, or have poor response to other treatments.
Reference materials:https://www.veozah.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)